Your browser doesn't support javascript.
loading
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France.
Houédé, Nadine; Beuzeboc, Philippe; Gourgou, Sophie; Tosi, Diego; Moise, Laura; Gravis, Gwenaëlle; Delva, Remy; Fléchon, Aude; Latorzeff, Igor; Ferrero, Jean-Marc; Oudard, Stéphane; Tartas, Sophie; Laguerre, Brigitte; Topart, Delphine; Roubaud, Guilhem; Agherbi, Hanane; Rebillard, Xavier; Azria, David.
Afiliação
  • Houédé N; Department of Medical Oncology, Nîmes University Hospital, Nîmes, France. nadine.houede@chu-nimes.fr.
  • Beuzeboc P; INSERM U1194, Montpellier, France. nadine.houede@chu-nimes.fr.
  • Gourgou S; Department of Medical Oncology, Curie Institute, Paris, France. philippe.beuzeboc@curie.net.
  • Tosi D; Biostatistics Unit, ICM - Montpellier Cancer Institute, Montpellier, France. sophie.gourgou@icm.unicancer.fr.
  • Moise L; Department of Medical Oncology, ICM - Montpellier Cancer Institute, Montpellier, France. diego.tosi@icm.unicancer.fr.
  • Gravis G; Department of Medical Oncology, François Baclesse Cancer Centre, Caen, France. l.moise@baclesse.fr.
  • Delva R; Department of Medical Oncology, Paoli Calmette Institute, Marseille, France. gravisg@ipc.unicancer.fr.
  • Fléchon A; Department of Medical Oncology, Paul Papin Cancer Centre, Angers, France. r.delva@unimedia.fr.
  • Latorzeff I; Department of Medical Oncology, Leon Bérard Cancer Centre, Lyon, France. aude.flechon@lyon.unicancer.fr.
  • Ferrero JM; Clinique Pasteur, Toulouse, France. i.latorzeff@clinique-pasteur.com.
  • Oudard S; Department of Medical Oncology, Antoine Lacassagne Cancer Centre, Nice, France. jean-marc.ferrero@nice.unicancer.fr.
  • Tartas S; Department of Medical Oncology, Georges Pompidou European Hospital, Paris, France. stephane.oudard@egp.aphp.fr.
  • Laguerre B; Department of Medical Oncology, Lyon University Hospital, Lyon, France. sophie.tartas@chu-lyon.fr.
  • Topart D; Department of Medical Oncology, Eugène Marquis Cancer Centre, Rennes, France. b.laguerre@rennes.unicancer.fr.
  • Roubaud G; Department of Medical Oncology, Montpellier University Hospital, Montpellier, France. d-topart@chu-montpellier.fr.
  • Agherbi H; Department of Medical Oncology, Bergonié Cancer Institute, Bordeaux, France. g.roubaud@bordeaux.unicancer.fr.
  • Rebillard X; INSERM U1194, Montpellier, France. hanane.agherbi@inserm.fr.
  • Azria D; Department of Urology, Clinique Beausoleil, Montpellier, France. xavier.rebillard@wanadoo.fr.
BMC Cancer ; 15: 222, 2015 Apr 04.
Article em En | MEDLINE | ID: mdl-25884302
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona / Antineoplásicos Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: França País de publicação: Reino Unido